Abstract
ASD is characterized by variable presentation of difficulties with socialization, communication, and restrictive/repetitive behaviors (RRB), for which no established pharmacological treatment exists. Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention with near-infrared light to forebrain. It is absorbed by cytochrome c oxidase in mitochondria and increases energy metabolism, leading to cellular plasticity and cytoprotection. Recently, TLT was found to be safe and effective in the treatment of depression. Effects of TLT on ASD symptoms remains to be explored.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
